[12,19] In addition to optimizing intravascular volume, nephrologists usually prescribe antihypertensive drugs. A national survey found that 75% of new hemodialysis patients and 60% of patients ...

Scientists have identified a widely prescribed hypertension drug as a potential key to extending lifespan and slowing aging.

The FDA has removed the risk evaluation and mitigation strategies (REMS) program requirement for Tryvio (aprocitentan).

A new study has found that taking medicine for high blood pressure may lower the risk of dementia in older adults. This ...

Mineralys Therapeutics enjoyed a big stock bump after its aldosterone synthase inhibitor chalked up wins in two types of hypertension.

The first step in treating hypertensive cardiovascular disease is treating the high blood pressure that’s causing it. That can be done in several ways, including prescribed medications and ...

Among patients with isolated systolic hypertension and frailty, antihypertensive therapy is associated with improved outcomes.

Two pivotal trials of the aldosterone synthase inhibitor have shown positive results for lorundrostat in uncontrolled and ...

Primary endpoints of both Advance-HTN and Launch-HTN studies, using lorundrostat to treat patients with hypertension were met with statistical significance. Read the full stock report here.